🔎 Trials Near Me

Home › Cancer (all types) › Vermont

Cancer (all types) clinical trials in Vermont

7 studies for Cancer (all types) are looking for participants at sites in Vermont.

Cities in Vermont

Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance

  • White River Junction Veterans Healthcare System, White River Junction
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT05796375

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • The University of Vermont Medical Center Inc., Burlington
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06119581

Project: Every Child for Younger Patients With Cancer

  • University of Vermont and State Agricultural College, Burlington
RecruitingObservational study
Up to age 25 · All sexes · Updated Aug 25, 2026 · NCT02402244

Expanding the Support of Family Caregivers of Diverse Patients With Cancer and Diabetes

  • University of Vermont Cancer Center, Burlington
RecruitingHealthy volunteers welcome
Ages 18 to 99 · All sexes · Updated Aug 10, 2026 · NCT07061652

Care Coordination Educational Intervention Study for Patients From Rural Areas With Early Stage Cancer

  • University of Vermont Cancer Center, Burlington
Recruiting
Ages 18 and older · All sexes · Updated May 4, 2026 · NCT05723250

DOAC - Dosing Options in AntiCoagulation Prophylaxis

  • University of Vermont Medical Center, Burlington
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Feb 5, 2026 · NCT07005024

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

  • University of Vermont Medical Center, Burlington
  • University of Vermount and Sate Agricultural College, Burlington
Recruiting
Ages 18 and older · All sexes · Updated Nov 27, 2024 · NCT03860883

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.